Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$148.35
▼ $1.19 (−0.80%) today
Markets closed · 6:44pm ET

MRK Coverage

Page 68
2:54am ET
Media

Media Digest 7/24/2009 Reuters, WSJ, NYTimes, FT. Bloomberg

Reuters: Microsoft’s (MSFT) results and forecast were weak. Reuters:   CIT (CIT) may sell its aviation finance business. Reuters:   Fatigue at the Fed is leading to questions about its expanded role. Reuters:   Twitter…

Douglas A. McIntyre
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre
6:27am ET
Investing

DJIA Component Earnings Trifecta (DD, MRK, UTX)

So far we have three DJIA components with earnings out.  DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings.  So far there are no train…

Douglas A. McIntyre
5:46am ET
Investing

Short Interest In Banks Plunges

The short interest in most large banks fell very sharply for the period ending May 29, an indication that traders believe that TARP repayments and ongoing strong earnings mean the fate of American…

Douglas A. McIntyre
3:00am ET
Investing

Media Digest 6/4/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   GM and Chrysler said closing dealers was essential to their restructuring. Reuters:   The Justice Department is probing big tech employee recruiting. Reuters:   Medical bills underlay 60% of American bankruptcies.

Douglas A. McIntyre
8:46pm ET
Investing

Ten Women Who Should Be Big Company CEOs

Twelve of the Fortune 500 CEOs are women. Just twelve. Over the next year, that number is likely to go up considerably because of a confluence of economic and financial factors that…

Douglas A. McIntyre